Established in 2004, the Stanford Cardiovascular Institute ignites new research and clinical applications through awarded seed grants, establishes educational and training programs in the field of cardiovascular medicine and research, and fosters an environment that supports diversity, equity, and inclusion. The CVI supports activities outside the bench and clinic that facilitate an exchange of ideas through seminars that are open to all members.
Emerging Stories
Events and Programs
Apr April 22 Tue 2025
Frontiers in Cardiovascular Science
Changes in Mitochondrial Ca2+ Levels in Heart and Muscle Are Linked to Metabolic Output
Jeff Molkentin, PhD
Director, Division of Molecular Cardiovascular Biology
Executive Co-Director, Heart Institute
Professor, UC Department of Pediatrics
Apr April 28 - 29 Mon-Tue 2025
SDDS 2025: Stanford Drug Discovery Symposium
The Stanford Drug Discovery Symposium has become a cornerstone in the drug discovery community for networking and collaboration. SDDS 2025 offers a unique opportunity for all members of the drug discovery community—including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community—to share ideas and innovations.
Stay Informed, Get Involved
CVI Leadership
Joseph C. Wu, MD, PhD
Director, Stanford Cardiovascular Institute
Simon H. Stertzer, MD, Professor
Department of Medicine (Cardiology) & Radiology
Contact Us
Stanford Cardiovascular Institute
265 Campus Drive
Stanford, CA 94305
(650) 723-9126
email